checkAd
    Startseite > Aktien > Neuronetics > Nachrichten
    Neuronetics
    Aktie
    ISIN: US64131A1051 WKN: A2JPMY SYM: STIM Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    2,0200
     
    USD
    -1,94 %
    -0,0400 USD
    Letzter Kurs 15.06.24 Nasdaq
    Geldkurs
    14.06.24
    1,9900
     
    USD
    300 STK
    Briefkurs
    14.06.24
    2,0200
     
    USD
    1.200 STK

    Neuronetics Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
    13.06.24 · globenewswire · Neuronetics
    Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference
    23.05.24 · globenewswire · Neuronetics
    Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
    15.05.24 · globenewswire · Neuronetics
    Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
    07.05.24 · globenewswire · Neuronetics
    Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    03.05.24 · globenewswire · Neuronetics
    NeuroStar TMS Advances Treatment for Adolescents During Mental Health Awareness Month
    01.05.24 · globenewswire · Neuronetics
    Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
    23.04.24 · globenewswire · Neuronetics
    New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
    10.04.24 · globenewswire · Neuronetics
    Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    27.03.24 · globenewswire · Neuronetics
    NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
    25.03.24 · globenewswire · Neuronetics
    Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
    07.03.24 · globenewswire · Neuronetics
    Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
    05.03.24 · globenewswire · Neuronetics